MorphoSys (MOR) has announced that it reached an agreement with Novartis (NVS) based on Novartis' intention to submit a voluntary public takeover offer for all of MorphoSys' outstanding common shares. The proposed offer includes a payment of 68.00 euros per share in cash, resulting in a total equity value of 2.7 billion euros.
The offer price corresponds to a premium of 94% and 142% on the volume-weighted average price during the last month and three months as of the unaffected January 25, 2024 close, respectively - the day before rumors about a transaction first surfaced. It also represents a premium of 89% percent to the closing share price of January 25, 2024.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.